The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes

Diabetologia

Volumn 55, Issue 5, 2012, Pages 1265-1272

  Shields, B M ^a   McDonald, T J ^b   Ellard, S ^b   Campbell, M J ^c   Hyde, C ^a   Hattersley, A T ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Clinical characteristics; Maturity onset diabetes of the young; MODY; Prediction model

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; COMPUTER MODEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIET THERAPY; DISEASE CLASSIFICATION; FAMILY HISTORY; FEMALE; GENETIC SCREENING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MATURITY ONSET DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX; VALIDATION STUDY;

ADOLESCENT; ADULT; AGE OF ONSET; BODY MASS INDEX; CHILD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN; LOGISTIC MODELS; MALE; MODELS, BIOLOGICAL; PREVALENCE; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; YOUNG ADULT;

EID: 84862526033     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2418-8     Document Type: Article

References (26)

1. Tattersall RB (1974) Mild familial diabetes with dominant inheritance. Q J Med 43:339-357
2. Tattersall RB, Fajans SS (1975) A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 24:44-53
3. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S (2010) Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 53:2504-2508
4. Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, Attersley AT (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362:1275-1281
5. Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT (2009) A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 26:437-441
6. Pearson ER, Velho G, Clark P et al (2001) Beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations. Diabetes 50(Suppl 1):S101-S107
7. Froguel P, Zouali H, Vionnet N et al (1993) Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702
8. Schober E, Rami B, Grabert M et al (2009) Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med 26:466-473
9. Galler A, Stange T, Muller G et al (2010) Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the childhood diabetes registry of Saxony, Germany. Horm Res Paediatr 74:285-291
10. Eide SA, Raeder H, Johansson S et al (2008) Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study). Diabet Med 25:775-781
11. Ledermann HM (1995) Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? Diabetologia 38:1482
12. Fajans SS, Bell GI, Bowden DW, Halter JB, Polonsky KS (1994) Maturity-onset diabetes of the young. Life Sci 55:413-422
13. Owen KR, Thanabalasingham G, James TJ et al (2010) Assessment of high-sensitivity C-reactive protein levels as diagnostic discriminator of maturity-onset diabetes of the young due to HNF1A mutations. Diabetes Care 33:1919-1924
14. Ellard S, Bellanne-Chantelot C, Hattersley AT (2008) Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 51:546-553
15. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al (1997) A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 89:1758-1762
16. Wells PS, Anderson DR, Rodger M et al (2000) Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 83:416-420
17. Royal College of General Practitioners and NHS Diabetes (2011) Coding, Classification and Diagnosis of Diabetes. Available from www.diabetes.nhs.uk/ our-work-areas/classification-of-diabetes/2011, accessed 16 Aug 2011
18. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA (1995) Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 73:17-24
19. Besser RE, Shepherd MH, McDonald TJ et al (2011) Urinary Cpeptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1 α /hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 34:286-291
20. McDonald TJ, Colclough K, Brown R et al (2011) Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from type 1 diabetes. Diabet Med 28(9):1028-1033
21. Ehtisham S, Hattersley AT, Dunger DB, Barrett TG (2004) First UK survey of paediatric type 2 diabetes and MODY. Arch Dis Child 89:526-529
22. Rosenbloom AL, Joe JR, Young RS, Winter WE (1999) Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22:345-354
23. Barker JM (2006) Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening. J Clin Endocrinol Metab 91:1210-1217
24. Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppala P (1986) Plasma and urinary C-peptide in the classification of adult diabetics. Scand J Clin Lab Invest 46:655-663
25. Menzel R, Kaisaki PJ, Rjasanowski I, Heinke P, KernerW,Menzel S (1998) A low renal threshold for glucose in diabetic patients with a mutation in the hepatocyte nuclear factor-1alpha (HNF-1alpha) gene. Diabet Med 15:816-820
26. Stride A, Vaxillaire M, Tuomi T et al (2002) The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia 45:427-435